scholarly journals Pycnalin, a New α-Glucosidase Inhibitor from Acer pycnanthum

2011 ◽  
Vol 59 (5) ◽  
pp. 672-675 ◽  
Author(s):  
Ai Ogawa ◽  
Yusaku Miyamae ◽  
Atsushi Honma ◽  
Tomoyuki Koyama ◽  
Kazunaga Yazawa ◽  
...  
Keyword(s):  
Glucosidase Inhibitor ◽  
Acer Pycnanthum

ChemInform Abstract: Pycnalin (I), a New α-Glucosidase Inhibitor from Acer pycnanthum.

ChemInform ◽  
2011 ◽  
Vol 42 (45) ◽  
pp. no-no
Author(s):  
Ai Ogawa ◽  
Yusaku Miyamae ◽  
Atsushi Honma ◽  
Tomoyuki Koyama ◽  
Kazunaga Yazawa ◽  
...  
Keyword(s):  
Glucosidase Inhibitor ◽  
Acer Pycnanthum

α-amylase and α-glucosidase inhibitor activities of secondary metabolites from Arcytophyllum thymifolium

Planta Medica ◽  
2016 ◽  
Vol 81 (S 01) ◽  
pp. S1-S381
Author(s):  
M De Leo ◽  
A Braca ◽  
MB Vera Saltos ◽  
I Faraone ◽  
N Malafronte ◽  
...  
Keyword(s):  
Secondary Metabolites ◽  
Glucosidase Inhibitor

Treatment of feline diabetes mellitus using an α-glucosidase inhibitor and a low-carbohydrate diet

2003 ◽  
Vol 5 (3) ◽  
pp. 183-189 ◽  
Author(s):  
EM Mazzaferro ◽  
DS Greco ◽  
AS Turner ◽  
MJ Fettman
Keyword(s):  
Diabetes Mellitus ◽  
Body Fat ◽  
Effective Means ◽  
Serum Glucose ◽  
Carbohydrate Diet ◽  
Low Carbohydrate Diet ◽  
Glucosidase Inhibitor ◽  
Naturally Occurring ◽  
Insulin Dependence ◽  
Low Carbohydrate

The purpose of this study was to determine the effect of an α-glucosidase inhibitor (acarbose), combined with a low-carbohydrate diet on the treatment of naturally occurring diabetes mellitus in cats. Eighteen client-owned cats with naturally occurring diabetes mellitus were entered into the study. Dual-energy X-ray absorptiometry (DEXA) was performed prior to and 4 months after feeding the diet to determine total body composition, including lean body mass (LBM) and percent body fat. Each cat was fed a commercially available low-carbohydrate canned feline diet and received 12.5 mg/cat acarbose orally every 12 h with meals. All cats received subcutaneous insulin therapy except one cat in the study group that received glipizide (5 mg BID PO). Monthly serum glucose and fructosamine concentrations were obtained, and were used to adjust insulin doses based on individual cat's requirements. Patients were later classified as responders (insulin was discontinued, n=11) and non-responders (continued to require insulin or glipizide, n=7). Responders were initially obese (<28% body fat) and non-responders had significantly less body fat than responders (<28% body fat). Serum fructosamine and glucose concentrations decreased significantly in both responder and non-responder groups over the course of 4 months of therapy. Better results were observed in responder cats, for which exogenousinsulin therapy was discontinued, glycemic parameters improved, and body fat decreased. In non-responders, median insulin requirements decreased and glycemic parameters improved significantly, despite continued insulin dependence. The use a low-carbohydrate diet with acarbose was an effective means of decreasing exogenous insulin dependence and improving glycemiccontrol in a series of client-owned cats with naturally occurring diabetes mellitus.

Sign in / Sign up

Export Citation Format

Share Document